News

Enhancing Urgent Care with WellNow and EB Medicine Collaboration

Enhancing Urgent Care with WellNow and EB Medicine Collaboration

WellNow and EB Medicine Join Forces for Enhanced Training

Industry leaders have united to redefine urgent care education and reinforce clinician confidence across the nation.

Strategic Partnership Overview

WellNow Urgent Care, recognized as a leader in the urgent care field with a rapidly expanding presence, has initiated a strategic collaboration with EB Medicine. This alliance aims to implement an innovative clinical education and training program designed for over 600 clinicians at more than 150 locations nationwide. The initiative reflects WellNow's steadfast commitment to clinical excellence and the provision of evidence-based care.

Comprehensive Clinical Education Access

Through this partnership, all WellNow clinicians will enjoy complete access to EB Medicine's platform tailored for urgent care education. This platform is rich in CME-accredited content and offers a variety of resources including procedure-specific courses, pediatric training modules, and clinical decision-making support tools. Additionally, it features guidance on charting practices, strategies for risk management, and mobile access for real-time updates, which is essential in the dynamic environment of urgent healthcare.

Quotes from Leadership

Dr. Robert Biernbaum, the Chief Medical Officer at WellNow Urgent Care, emphasized the organization’s focus on high-quality care. He stated, "At WellNow, we’re dedicated to fostering an environment where our clinicians thrive. Partnering with EB Medicine empowers us to strengthen clinical excellence in our clinics, enhance onboarding and skills development, and ensure our teams deliver reliable, high-quality care."

Features of the Education Program

The innovative training program includes widespread access to:

  • Evidence-Based Urgent Care, a monthly peer-reviewed journal exploring a single subject in depth.
  • The Urgent Care EKG Course, aimed at enhancing real-world EKG interpretation skills.
  • The Pediatric Urgent Care Playbook, which provides tried-and-true guidelines for common pediatric issues.
  • Safeguarding Charting, a course focusing on best practices for mitigating medical-legal risks through documentation.
  • Specialized modules for procedural teachings, including management of abscesses, laceration repairs, wound care, and orthopedic practices.

Additional Resources Provided

Further supporting clinicians, EB Medicine will distribute 160 hands-on suture kits annually and offer video modules on antibiotic and steroid stewardship. A pocket guide for antibiotic prescribing and skill workshops led by educator Dr. Patrick O'Malley will also be part of the offering. Stephanie Williford, CEO of EB Medicine, reflected on the enduring impact of evidence-based education, asserting, "Our collaboration with WellNow facilitates a broad-reaching effect across their entire system to enhance patient care, improve clinician retention, and strengthen operational efficiency."

Implementation of the New Platform

The educational platform is being swiftly implemented across the WellNow network. Clinicians are granted direct login access, comprehensive onboarding resources, and continuous opportunities for CME engagement.

About WellNow Urgent Care

WellNow Urgent Care stands out as one of the fastest-growing providers of urgent medical services, telehealth, and occupational medicine in the nation, featuring more than 150 locations across various states. They prioritize innovation and patient-focused care. WellNow is committed to providing accessible healthcare seven days a week, with services like extended hours, online check-ins, and around-the-clock virtual care. For further inquiries, individuals can visit WellNow's website.

About EB Medicine

For over 25 years, EB Medicine has set the standard in continuing clinical education focused on emergency and urgent care. By supplying practical, high-quality resources based on evidence, EB Medicine equips acute care professionals with the confidence to make informed decisions in critical situations. Their peer-reviewed materials are widely trusted by practitioners across the nation. Additional information can be found on EB Medicine's official site.

Frequently Asked Questions

What is the purpose of the partnership between WellNow and EB Medicine?

The partnership aims to enhance the clinical education and training of WellNow's clinicians to ensure high-quality patient care and support clinical excellence.

What type of resources will WellNow clinicians have access to?

Clinicians will have access to CME-accredited content, clinical decision support tools, and educational courses focused on various urgent care topics.

How does the program support pediatric care?

The program includes The Pediatric Urgent Care Playbook, which provides established guidelines and insights for managing common pediatric complaints.

Who will lead the educational workshops?

Workshops will be conducted by nationally renowned educator Dr. Patrick O'Malley, who will provide hands-on learning opportunities.

How does WellNow prioritize clinician success?

WellNow focuses on empowering its clinicians through comprehensive training programs, fostering an environment that encourages clinical excellence and professional growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 20

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 21

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading